Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 3, 2008, Pages 313-317

  Zhang, Mang Li ^a   Lu, Sen ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Epigenesis; Genetic; Pancreatic neoplasms; Pituitary tumor derived transforming gene

Indexed keywords

DNA; MESSENGER RNA; ONCOPROTEIN; PITUITARY TUMOR DERIVED TRANSFORMING PROTEIN 1; RESTRICTION ENDONUCLEASE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; EPIGENESIS, GENETIC; HUMANS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANS-ACTIVATORS;

EID: 46049105303     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M, Kloppel G. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003;442:444-452.
2. Calvisi DF, Simile MM, Ladu S, Pellegrino R, De Murtas V, Pinna F, et al. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer 2007;121: 2410-2420.
3. Bernal JA, Luna R, Espina A, Lázaro I, Ramos-Morales F, Romero F, et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002;32:306-311.
4. Heaney AP, Horwitz GA, Wang Z, Singson, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth actor expression in prolactinoma pathogenesis. Nat Med 1999;5:1317-1321.
5. Tang RF, Wang SX, Zhang FR, Peng L, ng SX, Xiao Y, et al. Interleukin-lalpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer. Hepatobiliary Pancreat Dis Int 2005;4:460-463.
6. Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H, et al. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains. J Cell Biochem 2003;90:819-836.
7. Kim DS, Fong J, Read ML, McCabe CJ. The emerging role of pituitary tumour transforming gene (PTTG) in endocrine tumourigenesis. Mol Cell Endocrinol 2007;278: 1-6.
8. Sakata H, Rubin JS, Taylor WG, Miki T. A Rho-specific exchange factor Ect2 is induced from S to M phases in regenerating mouse liver. Hepatology 2000;32:193-199.
9. Lai Y, Xin D, Bai J, Mao Z, Na Y. The important anti-apoptotic role and its regulation mechanism of PTTG1 in UV-induced apoptosis. J Biochem Mol Biol 2007;40:966-972.
10. Vaillant I, Paszkowski J. Role of histone and DNA methylation in gene regulation. Curr Opin Plant Biol 2007; 10:528-533.
11. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 2000;19:5298-5302.
12. Miki T, Smith CL, Long JE, Eva A, Fleming TP. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 1993;362:462-465.
13. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-1162.
14. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003;63: 4158-4166.
15. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-4530.
16. Hofmann W, Schlag PM. BRCA1 and BRCA2 - breast cancer susceptibility genes. J Cancer Res Clin Oncol 2000; 126:487-496.
17. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428.
18. Maloisel L, Rossignol JL. Suppression of crossing-over by DNA methylation in Ascobolus. Genes Dev 1998;12:1381-1389.
19. Clark SJ, Melki J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 2002;21:5380-5387.